Ocugen, Inc.

Nasdaq:OCGN

Biological Products, (No Diagnostic Substances)·MALVERN, PA

CEO

Musunuri Shankar

Financials

20 shown

Type	Period	Ended	Filed
10-K	FY 2025	12/31/25	3/4/26	→
10-Q	Q3 2025	9/30/25	11/5/25	→
10-Q	Q2 2025	6/30/25	8/4/25	→
10-Q	Q1 2025	3/31/25	5/9/25	→
10-K	FY 2024	12/31/24	3/5/25	→
10-Q	Q3 2024	9/30/24	11/14/24	→
↓

Earnings Releases (8-K)

15 shown

Filed	Period
3/4/26	Q1 FY2026	→
11/5/25	Q4 FY2025	→
8/1/25	Q3 FY2025	→
5/9/25	Q2 FY2025	→
3/5/25	Q1 FY2025	→
11/8/24	Q4 FY2024	→
↓

News (8-K)

65 shown

Filed	Type	Description
3/4/26	Other	Other Events	→
2/9/26	Exec Change	Departure or Appointment of Directors or Certain Officers	→
1/23/26	Reg FD	Regulation FD Disclosure	→
1/21/26	Agreement	Entry into a Material Definitive Agreement	→
1/15/26	Other	Other Events	→
12/18/25	Exec Change	Departure or Appointment of Directors or Certain Officers	→
↓

Prospectuses & Registrations

40 shown

Filed	Form	Description
3/4/26	S-8	S-8	→
1/21/26	424B5	424B5	→
8/11/25	424B5	424B5	→
4/25/25	ARS	ARS	→
3/5/25	S-8	S-8	→
1/31/25	S-3	S-3	→
↓

Filing History(846 filings)

TypeDateAccessionPeriodSize

Mar 5, 2026

0001470831-26-000245INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Mar 4, 2026

9.0 KB

S-8

Mar 4, 2026

0001104659-26-023323FORM S-8

—

178.1 KB

10-K

Mar 4, 2026

0001628280-26-01443510-K

Dec 31, 2025

8.9 MB

8-K

Mar 4, 2026

0001104659-26-023290FORM 8-K

Mar 4, 2026

306.0 KB

8-K

Mar 4, 2026

0001104659-26-023288FORM 8-K

Mar 4, 2026

14.0 MB

8-K

Feb 9, 2026

0001104659-26-011765FORM 8-K

Feb 9, 2026

276.8 KB

SCHEDULE 13G

Jan 30, 2026

0000102909-26-000152

—

6.8 KB

8-K

Jan 23, 2026

0001104659-26-006031FORM 8-K

Jan 22, 2026

208.9 KB

8-K

Jan 21, 2026

0001104659-26-005454FORM 8-K

Jan 20, 2026

522.9 KB

424B5

Jan 21, 2026

0001104659-26-005452424B5

—

503.1 KB

8-K

Jan 15, 2026

0001104659-26-003900FORM 8-K

Jan 15, 2026

7.4 MB

Jan 6, 2026

0001470831-26-000020STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Jan 2, 2026

7.8 KB

Jan 6, 2026

0001470831-26-000019STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Jan 2, 2026

7.0 KB

8-K

Dec 18, 2025

0001104659-25-122610FORM 8-K

Dec 12, 2025

183.7 KB

SCHEDULE 13G

Dec 8, 2025

0001274173-25-000339

—

9.2 KB

10-Q

Nov 5, 2025

0001372299-25-00001310-Q

Sep 30, 2025

18.3 MB

8-K

Nov 5, 2025

0001104659-25-106664FORM 8-K

Nov 5, 2025

3.3 MB

SCHEDULE 13G/A

Oct 31, 2025

0000102909-25-000248

—

6.1 KB

8-K

Sep 18, 2025

0001104659-25-091097FORM 8-K

Sep 16, 2025

184.0 KB

8-K

Sep 16, 2025

0001104659-25-090113FORM 8-K

Sep 11, 2025

189.7 KB

8-K

Sep 5, 2025

0001104659-25-087801FORM 8-K

Aug 29, 2025

195.2 KB

8-K

Aug 11, 2025

0001104659-25-075956FORM 8-K

Aug 8, 2025

739.6 KB

424B5

Aug 11, 2025

0001104659-25-075953424B5

—

459.9 KB

10-Q

Aug 4, 2025

0001628280-25-03731010-Q

Jun 30, 2025

6.1 MB

8-K

Aug 1, 2025

0001104659-25-072992FORM 8-K

Aug 1, 2025

3.6 MB

25 filings shown

Filed	Form	Description
4/25/25	DEFA14A	DEFA14A	→
4/25/25	DEF 14A	DEF 14A	→
6/18/24	DEFA14A	DEFA14A	→
5/28/24	DEF 14A	DEF 14A	→
5/17/24	PRE 14A	PRE 14A	→
6/21/23	DEFA14A	DEFA14A	→
↓

Ocugen, Inc.

Financials

Earnings Releases (8-K)

News (8-K)

Prospectuses & Registrations

Filing History(846 filings)

Proxies

Ownership

Other Filings

Filed	Form	Description
3/5/26	3	INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES	→
1/6/26	4	STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES	→
1/6/26	4	STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES	→
6/12/25	3/A	AMENDED INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES	→
6/9/25	4	STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES	→
6/9/25	4	STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES	→
↓

Filed	Form	Description
1/30/26	SCHEDULE 13G	SCHEDULE 13G	→
12/8/25	SCHEDULE 13G	SCHEDULE 13G	→
10/31/25	SCHEDULE 13G/A	SCHEDULE 13G/A	→
7/17/25	SCHEDULE 13G/A	SCHEDULE 13G/A	→
7/9/25	144	144	→
6/11/25	144	144	→
↓